尽管Nutrien没有达到预期的利,但却提高了股息,而Nutanix则超过预期,并提高了评级. Nutrien missed earnings estimates but raised its dividend, while Nutanix beat expectations and saw its rating upgraded.

Nutrien Ltd.报告Q4收入为每股0.83美元,略低于估计数,收入为51.2亿美元,低于预测。 Nutrien Ltd. reported Q4 earnings of $0.83 per share, slightly below estimates, with revenue of $5.12 billion, down from forecasts. 该公司将其季度股息提高到每股0.55美元,收益率为3.0%,分析员预测全年EPS为3.72美元。 The company raised its quarterly dividend to $0.55 per share, yielding 3.0%, and analysts project full-year EPS of $3.72. 华尔街维持“坚持”共识,价格目标从63美元到85美元不等。 Wall Street maintains a "Hold" consensus, with price targets ranging from $63 to $85. Nutanix第四季度业绩强劲，每股收益0.56美元，营收7.2283亿美元，同比增长10.4%，促使华尔街Zen将评级上调至“买入”。 Nutanix posted strong Q4 results, beating estimates with $0.56 EPS and $722.83 million in revenue, up 10.4% year-over-year, leading Wall Street Zen to upgrade its rating to "Buy." 2026年3月4日,该股票以40.70美元开放,市场上限为110.1亿美元,分析家前景喜忧参半。 The stock opened at $40.70 on March 4, 2026, with a market cap of $11.01 billion and a mixed analyst outlook.